Developing an AI digital therapeutic that meets both FDA Part 820 and ISO 13485 requirements is a complex but...
post-market surveillance
Digital therapeutics (DTx) sit at the intersection of healthcare and technology, demanding rigorous evidence to prove safety,...
In 2025, the regulatory landscape for AI‑driven medical diagnostics is tightening, with the FDA’s Quality System Regulation...
Securing CE marking for a digital health trial app under the Medical Devices Regulation (MDR) can be...
When a medical device is software‑only and intended to support clinical trial operations, the FDA classifies it...